Allogene Therapeutics
4.4K
Volume
+411%
Growth
exploding
About the Topic
Clinical-stage biotechnology company founded in 2017 and headquartered in South San Francisco, CA. The company is pioneering the development of allogeneic CAR T (AlloCAR T™) products for cancer and autoimmune diseases, differentiating itself by focusing on off-the-shelf cell therapies. The target demographic includes patients with cancer and autoimmune diseases seeking innovative cell therapy treatments.
Allogene Therapeutics was discovered on May 4th 2023 and it currently has a search volume of 4.4K with a growth of +411%.
Key Indicators
Growth
- Exploding
- Regular
- Peaked
Speed
- Exponential
- Constant
- Stationary
Seasonality
- High
- Medium
- Low
Volatility
- High
- Average
- Low
Members Only
Try Exploding Topics Pro
Get Free, Unlimited Access for 7 Days.
Categories
Save this topic and build your own trend dashboard.
Available with Exploding Topics Pro, try it now.
1.1M+ trends in our growing database.